Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich M Lauer

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Frontiers in Medicine|November 17, 2022
Determination of phage load and administration time in simulated occurrences of antibacterial treatmentsSteffen Plunder, Markus Burkard, Ulrich M Lauer, et al.
Clinical Microbiology Reviews|September 7, 2022
Reassessment of Historical Clinical Trials Supports the Effectiveness of Phage TherapyLuigi Marongiu, Markus Burkard, Ulrich M Lauer, et al.
International Journal of Oncology|July 4, 2019
Suicide gene‑armed measles vaccine virus for the treatment of AMLStefanie Maurer, Helmut R Salih, Irina Smirnow, et al.
Molecular Therapy Oncolytics|December 3, 2019
High-Affinity DARPin Allows Targeting of MeV to Glioblastoma Multiforme in Combination with Protease Targeting without Loss of PotencyJan R H Hanauer, Vivian Koch, Ulrich M Lauer, et al.
Human Gene Therapy. Clinical Development|June 17, 2014
Pulsed versus continuous application of the prodrug 5-fluorocytosine to enhance the oncolytic effectiveness of a measles vaccine virus armed with a suicide geneCan Yurttas, Susanne Berchtold, Nisar P Malek, et al.
Clinical Endocrinology|December 1, 2010
Severe gastrointestinal haemorrhage after methimazole intakeLena Minkley, Katrin Göhring-Frischholz, Klaus Mörike, et al.
Future Oncology (London, England)|June 14, 2022
Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumorsMercedes Porosnicu, Anne-Marie Quinson, Kate Crossley, et al.
Frontiers in Oncology|August 12, 2022
NUT Carcinoma-An Underdiagnosed MalignancyUlrich M Lauer, Martina Hinterleitner, Marius Horger, et al.
Wiener Medizinische Wochenschrift (1946)|May 1, 2015
Anti-proliferative activity of hop-derived prenylflavonoids against human cancer cell linesChristian Busch, Seema Noor, Christian Leischner, et al.
Plant Signaling & Behavior|April 19, 2016
Allelochemicals of the phenoxazinone class act at physiologically relevant concentrationsSascha Venturelli, Sebastian Petersen, Tobias Langenecker, et al.
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Frontiers in Medicine|November 17, 2022
Determination of phage load and administration time in simulated occurrences of antibacterial treatmentsSteffen Plunder, Markus Burkard, Ulrich M Lauer, et al.
Clinical Microbiology Reviews|September 7, 2022
Reassessment of Historical Clinical Trials Supports the Effectiveness of Phage TherapyLuigi Marongiu, Markus Burkard, Ulrich M Lauer, et al.
International Journal of Oncology|July 4, 2019
Suicide gene‑armed measles vaccine virus for the treatment of AMLStefanie Maurer, Helmut R Salih, Irina Smirnow, et al.
Molecular Therapy Oncolytics|December 3, 2019
High-Affinity DARPin Allows Targeting of MeV to Glioblastoma Multiforme in Combination with Protease Targeting without Loss of PotencyJan R H Hanauer, Vivian Koch, Ulrich M Lauer, et al.
Human Gene Therapy. Clinical Development|June 17, 2014
Pulsed versus continuous application of the prodrug 5-fluorocytosine to enhance the oncolytic effectiveness of a measles vaccine virus armed with a suicide geneCan Yurttas, Susanne Berchtold, Nisar P Malek, et al.
Clinical Endocrinology|December 1, 2010
Severe gastrointestinal haemorrhage after methimazole intakeLena Minkley, Katrin Göhring-Frischholz, Klaus Mörike, et al.
Future Oncology (London, England)|June 14, 2022
Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumorsMercedes Porosnicu, Anne-Marie Quinson, Kate Crossley, et al.
Frontiers in Oncology|August 12, 2022
NUT Carcinoma-An Underdiagnosed MalignancyUlrich M Lauer, Martina Hinterleitner, Marius Horger, et al.
Wiener Medizinische Wochenschrift (1946)|May 1, 2015
Anti-proliferative activity of hop-derived prenylflavonoids against human cancer cell linesChristian Busch, Seema Noor, Christian Leischner, et al.
Plant Signaling & Behavior|April 19, 2016
Allelochemicals of the phenoxazinone class act at physiologically relevant concentrationsSascha Venturelli, Sebastian Petersen, Tobias Langenecker, et al.
Pageof 15